(Q61965700)
Statements
A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific Immunotherapy With Racotumomab Plus Best Support Treatment Versus Best Support Treatment in Patients With Advanced Non-small Cell Lung Camcer. (English)
0 references
September 2010
0 references
September 2016
0 references
1,082
0 references
18 year
0 references